ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
46.19
+0.12 (0.26%)
Nov 12, 2025, 4:00 PM EST - Market closed
SBIO Holdings Information
SBIO is an equity ETF with a total of 103 individual holdings. The top holdings are Avidity Biosciences stock at 4.62%, Cytokinetics at 3.48%, Metsera at 3.27%, Axsome Therapeutics at 3.15%, and Merus at 3.11%.
Total Holdings
25
Top 10 Percentage
31.04%
Asset Class
Equity
ETF Category
Health
Assets
83.81M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | RNA | Avidity Biosciences, Inc. | 4.62% |
| 2 | CYTK | Cytokinetics, Incorporated | 3.48% |
| 3 | MTSR | Metsera, Inc. | 3.27% |
| 4 | AXSM | Axsome Therapeutics, Inc. | 3.15% |
| 5 | MRUS | Merus N.V. | 3.11% |
| 6 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.05% |
| 7 | NUVL | Nuvalent, Inc. | 2.75% |
| 8 | PCVX | Vaxcyte, Inc. | 2.58% |
| 9 | PTCT | PTC Therapeutics, Inc. | 2.52% |
| 10 | KRYS | Krystal Biotech, Inc. | 2.51% |
| 11 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.50% |
| 12 | ALKS | Alkermes plc | 2.43% |
| 13 | PTGX | Protagonist Therapeutics, Inc. | 2.31% |
| 14 | ACLX | Arcellx, Inc. | 2.10% |
| 15 | VKTX | Viking Therapeutics, Inc. | 2.06% |
| 16 | NAMS | NewAmsterdam Pharma Company N.V. | 2.04% |
| 17 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.89% |
| 18 | AKRO | Akero Therapeutics, Inc. | 1.88% |
| 19 | PRAX | Praxis Precision Medicines, Inc. | 1.77% |
| 20 | ACAD | ACADIA Pharmaceuticals Inc. | 1.77% |
| 21 | MIRM | Mirum Pharmaceuticals, Inc. | 1.58% |
| 22 | TVTX | Travere Therapeutics, Inc. | 1.58% |
| 23 | TARS | Tarsus Pharmaceuticals, Inc. | 1.50% |
| 24 | CELC | Celcuity Inc. | 1.47% |
| 25 | XENE | Xenon Pharmaceuticals Inc. | 1.38% |
Showing 25 of 103 holdings
Get a Stock Analysis Pro account to see the full list of holdings and get unlimited access to all data and
tools.
As of Nov 11, 2025